Ticker: LXRX

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) has recently provided financial updates for the quarter ended March 31, 2025, revealing both positive and negative aspects of its performance. Positive Aspects: Total revenues increased slightly to $1.3 million from $1.1 million year-over-year, indica...